This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Oesophageal Cancer
  • /
  • Ramucirumab monotherapy for previously treated adv...

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Read time: 1 mins
Published:25th Mar 2020
Author: Fuchs CS et al.
Source: The Lancet
Ref.:Lancet. 2014 Jan 4;383(9911):31-9.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest